Alveolar Bone Loss, Tooth Loss / Rehabilitation
Conditions
Brief summary
This retrospective observational study evaluated the clinical outcomes of simultaneous implant placement with horizontal ridge augmentation using autogenous mandibular ramus block grafts. Sixteen patients were treated between January 2018 and March 2025. Clinical and radiological data were analyzed to assess implant survival, osseointegration, and graft incorporation.
Detailed description
Horizontal alveolar bone deficiency is a significant challenge in implant rehabilitation. Traditional staged augmentation techniques prolong treatment time and increase morbidity. This study introduces a novel approach in which autogenous mandibular ramus block grafts were used to reconstruct buccal walls simultaneously with implant placement. Sixteen patients received 23 implants. Outcomes included implant survival, osseointegration success, bone healing, and complications during a mean follow-up of 30.6 months.
Interventions
Horizontal alveolar ridge augmentation performed using autogenous block grafts harvested from the mandibular ramus. The graft was fixed to reconstruct the buccal wall, followed by immediate placement of dental implants in the same surgical session. Prosthetic loading was initiated 4 months postoperatively.
Horizontal alveolar ridge augmentation performed using autogenous block grafts harvested from the mandibular ramus. The graft was fixed to reconstruct the buccal wall, followed by immediate placement of dental implants in the same surgical session. Prosthetic loading was initiated 4 months postoperatively.
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients ≥18 years of age * ASA I or II status * Presence of horizontal alveolar ridge deficiency requiring augmentation for implant placement * Treated with autogenous mandibular ramus block grafts and simultaneous implant placement * Provided informed consent for surgical and prosthetic procedures, and use of clinical and radiological data
Exclusion criteria
* Systemic conditions interfering with dental implant treatment (e.g., uncontrolled diabetes, metabolic bone disease) * Incomplete clinical or radiological records * Patients with contraindications for oral surgical procedures * Patients unwilling to provide informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| implant survival rate | 4 months post-surgery |
Countries
Turkey (Türkiye)